skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

376 Total results for product and free and sample content found

Meddevicetracker

Discover the top medtech stories from the last week below

21 Aug 2017

Meddevicetracker weekly round up

Topic Medtech weekly roundup

Pink Sheet

FDA Policy Says Right-to-Try Talks Are Between Providers, Sponsors

By Derrick Gingery 21 Aug 2017

New internal policy says the US agency cannot force a drug maker to supply an unapproved drug to a patient for expanded access.

Topic FDA

Scrip

Portola's AndexXa Antidote For Xarelto And Eliquis Finally On The Way

By Emily Hayes 21 Aug 2017

FDA approval of an antidote for Factor Xa novel anticoagulants would further drive the already strong uptake of J&J/Bayer's Xarelto and Bristol/Pfizer's Eliquis, analysts say.

Pink Sheet

South Africa To Tighten Up On Patenting To Promote Innovation, Improve Medicines Access

21 Aug 2017

Reforms proposed in the draft South African policy on intellectual property and public health that has just been put out for consultation have been welcomed.

Scrip

Liver Cancer: What's Close To The Market

By John Davis 21 Aug 2017

The treatment of liver cancer will have a makeover in coming months.

Topic Clinical trials

Pink Sheet

Medically Senseless: Why EU Pediatric Investigation Plans Should be Abandoned

20 Aug 2017

Most clinical trials required under EU pediatric investigation plans are medically senseless, and many cause harm to patients, argues consultant Klaus Rose.

Topic Clinical trials

Scrip

Sun Plunges To Quarterly Loss, Outlook Challenging

By Penelope MacRae 20 Aug 2017

Sun Pharma, India’s biggest drug firm, slid into the red in the first quarter, hit by a hefty legal payout.

Pink Sheet

Pharma Calls For Practical Advice On Using Risk-Based Approach To Trials in EU

By Vibha Sharma 20 Aug 2017

The pharmaceutical industry and other stakeholders are calling for practical advice on how the new EU guideline on using a risk-proportionate approach to clinical trials will be implemented.

Topic Clinical trials

Scrip

New Beginnings – How The Big Players Dominate Clinical Trial Starts

By Alex Shimmings 20 Aug 2017

AstraZeneca started the greatest number of clinical studies in 2016, finds Trialtrove's latest review, but a new kid on the block.

Topic Research

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907
  • Japan            : +81 3-6273-4257

Or email us your inquiry, so we can provide you the best possible customer service:
pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: